PARTNER INTERVIEW: PulsePoint
How HCP intelligence can sharpen your DTC strategy
In this Partner Interview sponsored by PulsePoint, Glenniss Richards, Senior Director of Media for Bayer Pharmaceuticals, and Malcolm Halle, Group Vice President at PulsePoint, join solli CEO Rich Springham to explore how HCP intelligence can strengthen DTC strategy.
The discussion examines the strategic advantage of starting with the physician. If HCPs are not informed or ready to prescribe, generating patient demand can create friction, waste media investment and limit campaign performance. By connecting physician insights with consumer targeting, brands can better align messaging, creative and channel selection across the prescribing journey.
Glenniss and Malcolm also explore how evolving data and technology can help organisations coordinate HCP and DTC activity more efficiently. Rather than measuring physician and patient engagement separately, they argue that success should reflect the synergy between both audiences, helping brands focus on the right patients, support better-informed conversations and ultimately drive stronger outcomes.
